Short- and mid-term outcomes of robotic-assisted total mesorectal excision for the treatment of rectal cancer. Our experience after 198 consecutive cases.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published Date: Mar 29, 2016

Abstract

BACKGROUND: Robot-assisted total mesorectal excision is a safe alternative for rectal cancer treatment. Nevertheless, substantial data is still missing. Our aim was to assess the perioperative and oncological outcomes of the routine use of the robotic-assisted approach for rectal cancer treatment.

Authors

  • M Gómez Ruiz
    Colorectal Division, Department of Surgery, Hospital Universitario "Marqués de Valdecilla", Santander, Spain. Electronic address: marcgomez@humv.es.
  • J Alonso Martin
    Colorectal Division, Department of Surgery, Hospital Universitario "Marqués de Valdecilla", Santander, Spain.
  • C Cagigas Fernández
    Colorectal Division, Department of Surgery, Hospital Universitario "Marqués de Valdecilla", Santander, Spain.
  • J I Martín Parra
    Colorectal Division, Department of Surgery, Hospital Universitario "Marqués de Valdecilla", Santander, Spain.
  • H Real Noval
    Colorectal Division, Department of Surgery, Hospital Universitario "Marqués de Valdecilla", Santander, Spain.
  • B Martín Rivas
    Colorectal Division, Department of Surgery, Hospital Universitario "Marqués de Valdecilla", Santander, Spain.
  • E Toledo Martínez
    Colorectal Division, Department of Surgery, Hospital Universitario "Marqués de Valdecilla", Santander, Spain.
  • J Castillo Diego
    Colorectal Division, Department of Surgery, Hospital Universitario "Marqués de Valdecilla", Santander, Spain.
  • M Gómez Fleitas
    Colorectal Division, Department of Surgery, Hospital Universitario "Marqués de Valdecilla", Santander, Spain; University of Cantabria, Santander, Spain.

Keywords

External Resources

Popular Topics
Recent Journals